Role of Vitamin D on Gastric Motility in Patients with Gastroparesis from Inflammatory Enteric Neuropathy (P05.198)
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: 1. To study the relationship between vitamin D levels and gastric motility in patients with gastroparesis ( GP) from inflammatory enteric neuropathy ( IEN)2. Prevalance of low vitamin D levels in patients with GP from IEN
Background IEN is a cause of GP and is characterized by presence of inflammatory cells in the myenteric plexus. Gastrointestinal dysmotility occurs from loss of innervation and additional factors such as deficiency in micronutrients play a role. Vitamin D is important for maintaining normal muscle tone and strength in skeletal muscles.
Design/Methods: Fifty nine consecutive patients with idiopathic gastroparesis from IEN were studied. Symptom scores, gastric emptying time, vitamin levels including vitamin D were measured. Vitamin D levels were correlated with gastric emptying time.
Results: Eleven of the 59 patients had diabetes mellitus( DM). 1'25 dihydroxy vitamin D3 levels were low in all (38.68±25.05 ng/ml), lower in DM (30.02±. The first hour gastric emptying correlated inversely with vitamin D levels (sl= -0.34)95% confidence interval -0.64, -0.03; p =0.033). The correlation was weaker with the 4 hour gastric emptying ( sl= -0.28, 95% confidence interval -0.61, to 0.04; p=0.086).
Conclusions: Vitamin D levels correlate with efficiency of gastric emptying in patients with GP from IEN, and correction of vitamin D deficiency in these patients will improve their gastrointestinal motility and symptoms related to it.
Disclosure: Dr. Kedar has nothing to disclose. Dr. Vedanarayanan has nothing to disclose. Dr. Nikitina has nothing to disclose. Dr. Griswold has nothing to disclose. Dr. Abell has received personal compensation for activities with Medtronic Inc as an instructor, licensor and consultant.
Wednesday, April 25 2012, 14:00 pm-19:00 pm
- Copyright © 2011 by AAN Enterprises, Inc.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.